Depression
Also known as: Major Depressive Disorder, Clinical Depression, MDD, Major Depression
Depression (major depressive disorder) is a common but serious mood disorder that causes persistent feelings of sadness, hopelessness, and loss of interest in activities once enjoyed. It affects how you feel, think, and handle daily activities such as sleeping, eating, and working. Depression is highly treatable through a combination of psychotherapy, medication, and lifestyle modifications, and seeking help is the most important first step.
Last updated October 31, 2026
Understanding Depression
Major depression is an illness of mood, energy, thinking and the body that lasts for weeks to months and does not lift with good news or a holiday. The low mood is only part of it, and for many people not the most obvious part: loss of pleasure in things that used to matter, waking at 4 a.m., moving and thinking as if through syrup, and a relentless inner voice insisting that everything is their fault are just as central. Episodes typically last six to nine months untreated, and about half of people who have one episode will have another. Depression is also a leading cause of disability worldwide and the main driver of suicide, which is why the threshold for asking for help should be low. If you are having thoughts of ending your life, call or text 988 in the United States, or your local crisis line, now; it is a confidential conversation, not a commitment to anything.
The old idea that depression is simply a serotonin shortage is too simple, but neurochemistry is still part of the picture. Serotonin, norepinephrine and dopamine signaling are altered, and drugs that modify them help many people. Beyond that, depression involves an overactive stress system, with elevated cortisol in about half of severe cases; low-grade inflammation, with raised C-reactive protein and inflammatory cytokines in roughly a quarter of people; reduced levels of brain-derived neurotrophic factor (BDNF), which supports the growth of new connections between neurons; and measurable shrinkage of the hippocampus with repeated episodes. Sleep architecture changes, with REM sleep arriving earlier and deeper sleep lost. Genes account for about 35 to 40 percent of risk, with early-life adversity and recent stress supplying much of the rest. The common thread is a brain that has become less plastic and more locked into negative patterns, which is why effective treatments, from antidepressants to exercise to therapy, all seem to restore plasticity.
Conventional treatment is matched to severity. For mild depression, guidelines recommend psychotherapy, structured exercise or guided self-help first. For moderate to severe depression, antidepressants and psychotherapy are both first-line, and together they outperform either alone. A 2018 network meta-analysis of 522 trials found all 21 antidepressants studied beat placebo; SSRIs such as sertraline and escitalopram are the usual starting point because they balance effectiveness and tolerability, with SNRIs, bupropion and mirtazapine as alternatives with different side-effect profiles. The honest numbers from the large STAR*D study are that about a third of people reach remission on the first antidepressant and two-thirds after up to four well-run treatment steps. CBT, behavioral activation and interpersonal therapy are as effective as medication for mild to moderate episodes and protect against relapse. For severe or treatment-resistant depression, esketamine nasal spray, transcranial magnetic stimulation and electroconvulsive therapy, which produces response in 70 to 80 percent of the most severe cases, are highly effective options.
Natural approaches have a stronger evidence base in depression than in almost any other mental health condition, with important limits. St John's wort has a Cochrane review of 29 trials showing it works as well as standard antidepressants for mild to moderate depression with fewer side effects, but it interacts with so many drugs that it needs the same respect as a prescription. Saffron has matched fluoxetine and imipramine in several small 6-week trials. EPA-dominant omega-3 adds a modest benefit on top of antidepressants. SAM-e, curcumin, L-methylfolate and rhodiola each have at least one good randomized trial. None of these has been tested in severe depression, and none should delay treatment for someone who cannot function or is thinking about suicide. Their best use is for mild to moderate episodes, or as adjuncts chosen with a prescriber who knows the interactions. Vitamin D helps only if you are low in it, which is common and cheap to check.
The most costly misunderstanding is believing that depression is a character flaw that should respond to willpower. The inability to get started, concentrate or care is the illness, not laziness, in the same way that breathlessness is asthma and not weakness. The second is stopping an antidepressant as soon as mood improves; relapse rates roughly double when treatment ends before six to twelve months of remission, because the brain changes that drive depression take longer to settle than the symptoms do. A third, quieter mistake is waiting: the average delay between a first episode and treatment is several years, and each untreated episode makes the next one more likely.
At a Glance
- Common symptoms
- Persistent sad, anxious, or empty mood, Loss of interest or pleasure in hobbies and activities, Fatigue and decreased energy
- Main treatments
- Selective serotonin reuptake inhibitors (SSRIs: sertraline, fluoxetine, escitalopram), Serotonin-norepinephrine reuptake inhibitors (SNRIs: venlafaxine, duloxetine), Cognitive behavioral therapy (CBT)
- Category
- Mental Health · Affects approximately 8.4% of U.S. adults (21 million people) annually
- See a doctor if
- Feelings of sadness or hopelessness persist for more than two weeks
Symptoms
Causes
- Imbalance of brain neurotransmitters (serotonin, norepinephrine, dopamine)
- Genetic predisposition
- Stressful or traumatic life events
- Chronic medical conditions
- Hormonal changes (postpartum, menopause, thyroid disorders)
Risk Factors
- Personal or family history of depression
- Major life changes, trauma, or chronic stress
- Certain medications (beta-blockers, corticosteroids)
- Substance abuse
- Chronic illness (cancer, diabetes, heart disease)
- Social isolation and lack of support
Diagnosis
- Clinical interview using DSM-5 criteria (5+ symptoms for 2+ weeks)
- Patient Health Questionnaire (PHQ-9) screening tool
- Physical examination to rule out medical causes
- Blood tests (thyroid function, vitamin D, B12, CBC)
Treatment
- Selective serotonin reuptake inhibitors (SSRIs: sertraline, fluoxetine, escitalopram)
- Serotonin-norepinephrine reuptake inhibitors (SNRIs: venlafaxine, duloxetine)
- Cognitive behavioral therapy (CBT)
- Interpersonal therapy (IPT)
- Regular exercise (shown to be as effective as medication for mild-moderate depression)
- Electroconvulsive therapy (ECT) or transcranial magnetic stimulation (TMS) for treatment-resistant cases
Natural remedies for depression: what the evidence says
Ranked by the strength of human evidence for depression specifically. These sit alongside medical care, not in place of it.
St John's Wort
Strong evidenceThe 2008 Cochrane review pooled 29 randomized trials with 5,489 people with major depression: St John's wort extracts were superior to placebo (response about 1.5 times more likely) and as effective as standard antidepressants including SSRIs, with about half as many dropouts for side effects. Trials used 500 to 1,200 mg/day of standardized extract for 4 to 12 weeks in mild to moderate depression; there is no good evidence in severe depression.
- Studied dose
- 300 mg of extract standardized to 0.3 percent hypericin (or 3 to 5 percent hyperforin) three times daily, 900 mg/day, for at least 6 weeks.
- Cautions
- Never combine with SSRIs, SNRIs, tramadol, triptans or MAOIs because of serotonin syndrome risk. It strongly induces liver enzymes and cuts blood levels of oral contraceptives (unplanned pregnancies reported), warfarin, digoxin, cyclosporine, tacrolimus, HIV antivirals, some chemotherapy, and many other drugs; it can cause sun sensitivity, trigger mania in bipolar disorder, and must be stopped 2 weeks before surgery. Avoid in pregnancy.
Saffron
Strong evidenceAt least 12 randomized trials, mostly 6 weeks long at 30 mg/day, have tested saffron in mild to moderate depression. Meta-analyses find a large effect over placebo and no significant difference from fluoxetine 20 mg or imipramine 100 mg in head-to-head trials, with fewer side effects. Trials as an add-on to an SSRI in people with residual symptoms also showed benefit. Most trials were small and from one country, which is the main limitation.
- Studied dose
- 30 mg/day of saffron stigma or petal extract, usually as 15 mg twice daily, for 6 to 12 weeks.
- Cautions
- Safe at this dose; above 5 g it is toxic. Avoid high doses in pregnancy (uterine stimulant), use caution with anticoagulants, and discuss with your prescriber before combining with an antidepressant because of additive serotonergic effects.
Omega-3 (EPA-dominant)
Strong evidenceA 2019 meta-analysis of 26 randomized trials (2,160 people) found omega-3 reduced depressive symptoms with a small-to-moderate effect, which became larger and more consistent in trials using formulas that were at least 60 percent EPA at 1 g/day or more, mostly as add-ons to antidepressants. DHA-dominant products did not work. Benefit appears greatest in people with raised inflammatory markers such as C-reactive protein.
- Studied dose
- 1 to 2 g of EPA per day from a fish oil with EPA at least 60 percent of total omega-3, for 8 to 12 weeks.
- Cautions
- Fishy aftertaste and loose stools are common. Mild blood-thinning effect, so tell your doctor if you take warfarin or antiplatelet drugs or face surgery; very high doses (4 g/day) have been linked to atrial fibrillation in cardiac trials.
SAM-e
Moderate evidenceSAM-e (S-adenosyl methionine) was compared with tricyclic antidepressants in a series of older European trials with similar response rates, and a US agency review in 2002 judged it effective versus placebo. In a 6-week 2010 trial of 73 people whose SSRI had not worked, adding 800 mg twice daily produced response in 36 percent versus 18 percent on placebo and remission in 26 percent versus 12 percent. A larger 2014 follow-up did not confirm the benefit, so the tier is Moderate.
- Studied dose
- 400 to 800 mg enteric-coated tablets twice daily on an empty stomach, starting low to limit nausea.
- Cautions
- Can trigger mania in bipolar disorder, causes nausea and restlessness, and may worsen Parkinson's symptoms. Combine with antidepressants only under supervision because of serotonin syndrome risk; it is expensive and degrades if not stored properly.
Curcumin
Moderate evidenceA 2020 meta-analysis of 9 randomized trials (531 people) found curcumin significantly reduced depressive symptoms compared with placebo with a moderate-to-large effect, mostly as an add-on to antidepressants over 6 to 12 weeks. In one 8-week trial of 56 people with major depression, 500 mg of a bioavailable extract twice daily outperformed placebo from week 4 onward. Trials were small and used different formulations, which limits confidence.
- Studied dose
- 500 mg of a bioavailable curcumin extract (such as BCM-95 or with piperine) twice daily for 8 to 12 weeks.
- Cautions
- Mild antiplatelet effect, so use caution with anticoagulants and before surgery. Avoid with gallstones or bile duct obstruction, and note that piperine-containing products can raise blood levels of many drugs.
Folate (L-methylfolate)
Moderate evidenceLow folate predicts poorer antidepressant response. In a 2012 pair of randomized trials, adding 15 mg/day of L-methylfolate to an SSRI in people who had not responded doubled the response rate in the second trial (32 percent versus 15 percent) over 60 days; 7.5 mg did not help. An older trial found 500 micrograms of folic acid improved response to fluoxetine in women. Benefit is likeliest in people with low folate or the MTHFR variant.
- Studied dose
- 15 mg/day L-methylfolate as an add-on to an antidepressant; or 400 to 800 micrograms folic acid daily if blood folate is low.
- Cautions
- High-dose folate can mask vitamin B12 deficiency, so check B12 first. It interacts with methotrexate and some anti-seizure drugs (phenytoin), and 15 mg L-methylfolate is a prescription product in the US.
Rhodiola Rosea
Moderate evidenceIn a 12-week randomized trial of 57 adults with mild to moderate depression, rhodiola (340 to 1,360 mg/day) produced a smaller improvement than sertraline, reaching about half the drug's effect, but with far fewer side effects (30 percent versus 63 percent). An earlier 6-week trial in 89 people found 340 to 680 mg/day of a standardized extract significantly outperformed placebo on depression scores. It suits people with fatigue-dominant mild depression who cannot tolerate antidepressants.
- Studied dose
- 340 to 680 mg/day of extract standardized to 3 percent rosavins and 1 percent salidroside, taken in the morning.
- Cautions
- Mildly stimulating; can cause insomnia or jitteriness if taken late. Avoid in bipolar disorder, use caution with antidepressants because of a theoretical serotonergic interaction, and there are no pregnancy safety data.
Vitamin D (if deficient)
Preliminary evidenceLow vitamin D is associated with depression, but randomized trials of supplementation have been inconsistent. Large trials in people who were not deficient, including the 18,000-person VITAL-DEP study, found no benefit for preventing depression. Smaller trials in people with low levels or existing depression, using 2,000 IU/day or more, have shown modest improvement in symptoms, so the honest conclusion is that correcting a deficiency helps and taking extra when levels are normal does not.
- Studied dose
- 1,000 to 4,000 IU vitamin D3 daily to correct a measured deficiency; recheck blood levels after 3 months.
- Cautions
- Long-term intake above 4,000 IU/day without monitoring risks high calcium and kidney stones. Use caution with thiazide diuretics, digoxin and in sarcoidosis or other granulomatous disease.
What matters day to day
- Exercise most days: a 2024 meta-analysis of 218 trials found walking or jogging, yoga and strength training each reduced depression with moderate effects, and a 16-week aerobic program matched sertraline in a classic trial of older adults.
- Eat a Mediterranean-style diet: in the 12-week SMILES trial, people with moderate to severe depression who received dietary coaching reached remission at four times the rate of the social-support control group (32 percent versus 8 percent).
- Treat insomnia as its own problem: CBT for insomnia in people with both conditions roughly doubles the chance of depression remission compared with sleep hygiene alone.
- Get morning light: 30 minutes of 10,000 lux bright light therapy outperformed fluoxetine in an 8-week trial of non-seasonal depression, and the combination did best of all.
- Schedule activity before motivation arrives: behavioral activation, which means planning small, valued activities and doing them regardless of mood, is as effective as full CBT and can be started on your own.
- Limit alcohol: it is a depressant, disrupts sleep in the second half of the night, and heavy use makes antidepressants about half as likely to work.
Prevention
- Maintain regular physical exercise
- Build and maintain strong social connections
- Practice stress management and mindfulness
- Get adequate sleep (7-9 hours per night)
- Limit alcohol consumption
- Seek early treatment if symptoms develop
When to See a Doctor
- Feelings of sadness or hopelessness persist for more than two weeks
- You lose interest in activities you previously enjoyed
- Depression interferes with work, relationships, or daily functioning
- You have thoughts of self-harm or suicide—call 988 Suicide and Crisis Lifeline
Frequently Asked Questions
References
- Linde K, Berner MM, Kriston L. St John's wort for major depression. Cochrane Database of Systematic Reviews (2008)
- Cipriani A, Furukawa TA, Salanti G, et al.. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet (2018)
- Hausenblas HA, Saha D, Dubyak PJ, Anton SD. Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials. Journal of Integrative Medicine (2013)
- Liao Y, Xie B, Zhang H, et al.. Efficacy of omega-3 PUFAs in depression: a meta-analysis. Translational Psychiatry (2019)
- Papakostas GI, Mischoulon D, Shyu I, et al.. S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial. American Journal of Psychiatry (2010)
- Papakostas GI, Shelton RC, Zajecka JM, et al.. L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. American Journal of Psychiatry (2012)
- Fusar-Poli L, Vozza L, Gabbiadini A, et al.. Curcumin for depression: a meta-analysis. Critical Reviews in Food Science and Nutrition (2020)
- Mao JJ, Xie SX, Zee J, et al.. Rhodiola rosea versus sertraline for major depressive disorder: a randomized placebo-controlled trial. Phytomedicine (2015)
- Jacka FN, O'Neil A, Opie R, et al.. A randomised controlled trial of dietary improvement for adults with major depression (the SMILES trial). BMC Medicine (2017)
- National Institute of Mental Health. Depression (2024)View source
Related Conditions
Lab tests that relate to depression
Related from the Supplement Library
St. John's Wort
StrongHerb · May improve mild-to-moderate depression
Omega-3 (EPA/DHA)
StrongFatty Acid · Cardiovascular health (TG reduction, anti-arrhythmic)
Vitamin D
StrongVitamin · Bone health and calcium absorption
SAM-e
ModerateAmino Acid · May improve depression symptoms
Rhodiola Rosea
ModerateAdaptogen · Reduces fatigue and burnout
Folate
StrongVitamin · DNA synthesis and repair
Saffron
ModerateHerb · Improves mild-to-moderate depressive symptoms
These supplements have been studied in relation to Depression. Always consult your healthcare provider before starting any supplement, especially if you take medications.
Related Reading
Best Supplements for Sleep: An Evidence-Based Ranking of What Actually Works
A science-backed ranking of the best natural supplements for sleep — magnesium, melatonin, L-theanine, glycine, valerian, and more — with what the research shows, how to dose them, and what to try first for insomnia.
Fibermaxxing: How to Increase Fiber Without Wrecking Your Gut
Fiber is one of the best-supported nutrition levers for gut, metabolic, and cardiovascular health. The hard part is increasing it slowly enough to avoid bloating. Here is the evidence, the ramp-up protocol, and the mistakes to avoid.
Washoku Diet and Depression Risk: What the 2025 Study Suggests
A 2025 study of more than 12,000 Japanese workers linked higher adherence to the traditional Washoku diet with lower depressive-symptom risk. Here is what the finding means, what it cannot prove, and how to use the pattern practically.
Have questions about Depression?
Ask Mother Nature AI for personalized, evidence-based guidance.
Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.
Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.